Cargando…
A comprehensive review of pancreatic cancer and its therapeutic challenges
Pancreatic cancer is a devastating and lethal human malignancy with no curable chemo-treatments available thus far. More than 90% of pancreatic tumors are formed from ductal epithelium as pancreatic ductal adenocarcinoma (PDAC), which often accompany with the expression of mutant K-ras. The incidenc...
Autores principales: | Jiang, Shan, Fagman, Johan Bourghardt, Ma, Yunyun, Liu, Jian, Vihav, Caroline, Engstrom, Cecilia, Liu, Beidong, Chen, Changyan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9550249/ https://www.ncbi.nlm.nih.gov/pubmed/36173644 http://dx.doi.org/10.18632/aging.204310 |
Ejemplares similares
-
Protein phase separation and its role in tumorigenesis
por: Jiang, Shan, et al.
Publicado: (2020) -
High expression of p62/SQSTM1 predicts shorter survival for patients with pancreatic cancer
por: Philipson, Eva, et al.
Publicado: (2022) -
EGFR, but not COX-2, protein in resected pancreatic ductal adenocarcinoma is associated with poor survival
por: Fagman, Johan Bourghardt, et al.
Publicado: (2019) -
Reduced tumor growth in EP2 knockout mice is related to signaling pathways favoring an increased local anti-tumor immunity in the tumor stroma
por: Khan, Maria, et al.
Publicado: (2022) -
Fractional uptake of circulating tumor cells into liver-lung compartments during curative resection of periampullary cancer
por: Vilhav, Caroline, et al.
Publicado: (2018)